50% off Premium Yearly

TSE:AGT
This has been a significant disappointment. He is looking at this more and more, because it has gotten hammered. The most recent investment by Fairfax got them out of a debt problem. We do pulses in Canada more than anyone else in the world, and that is good. The bigger issue is the importation, which has really hit the stock. India has some issues with our pulses. Pulses are a wonderful long-term play on the protein story. If they can fix their balance sheet and get over the India problem, then you might have a really good upside opportunity.
They’ve been hurt by tough lentil market conditions, and a lot of that has to do with what is happening in India. India had a requirement, effectively a tariff, where they wanted lentils going into India to be fumigated before they got there. They have now relaxed the restriction. However, that more than anything, depressed lentil prices, which is only about 5% of this company’s business. They are moving more downstream which should help stabilize the business. Dividend yield of 2.3%. (Analysts’ price target is $33.)
This has been an off year for them. The pulse market has been somewhat in the doldrums. The perennial problem with the fumigation issues on importing pulses into India, has surfaced again. Over time, the company has been diversifying into ingredients for human and pet consumption. They’ve recently just bought some more transportation access to a port facility. Dividend yield of 2.4%. (Analysts’ price target is $35.)
He understands this has been under attack from a US Short seller, which has really driven down the price. Technically the trend is lower highs and lower lows. It is resisting its 50-day moving average, and there is nothing positive from a technical perspective. There was a significant gap down between $30 and $27. Seasonally, agriculture has strength from now through to September and then dips in September to rise again to the end of the year. This one continues to go down.
(A Top Pick July 15/16. Down 24%.) A number of things have impacted this company. They had the supposedly fumigation problem with exports to India. Pulses are probably one of the fastest growing demand areas within the nutrition segments. They did very well last year, and the stock may have gotten ahead of itself. The 1st quarter was very disappointing. Rumours are that India is going to have a relatively poor crop, which is going to have them import more. At $25, it represents fairly good value.
Had a really tough quarter recently and the stock took a very big hit. It was really the wording of the company, reading between the lines, that gave a bit of cause for concern. They talked about weakening demand, political strife, change in the demand picture. He wouldn’t really care about that, but the company does have quite a lot of debt. A situation where you might want to back off for 2, 3 or 4 quarters to see how it plays out.
Sold his holdings a few weeks ago. Ostensibly, they have a lot of good things going for it. They are producers of pulses, beans, lentils, things that are really on trend with health foods. Management has had a consistent failure of executing a plan to street expectations. Their latest quarter had a pretty severe profit warning.
Ranks 578 out of 700, so is roughly in the bottom 3rd of the database. A recent report suggested headwinds for them. Earnings were down 82%. Earnings are expected to grow by 57%, but there seems to be some scepticism. You are better off looking at other opportunities.